Assenagon Asset Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $184K | Sell |
|
|||||
|
2025
Q2 | $238K | Sell |
|
|||||
|
2025
Q1 | $239K | Sell |
|
|||||
|
2024
Q4 | $615K | Sell |
|
|||||
|
2024
Q3 | $8.52M | Sell |
|
|||||
|
2024
Q2 | $8.45M | Buy |
|
|||||
|
2024
Q1 | $18.7M | Buy |
|
|||||
|
2023
Q4 | $610K | Sell |
|
|||||
|
2023
Q3 | $807K | Buy |
|
|||||
|
2023
Q2 | $475K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $327K | Sell |
|
|||||
|
2022
Q2 | $362K | Sell |
|
|||||
|
2022
Q1 | $566K | Sell |
|
|||||
|
2021
Q4 | $855K | Sell |
|
|||||
|
2021
Q3 | $7.38M | Sell |
|
|||||
|
2021
Q2 | $36.2M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $2.3M | Sell |
|
|||||
|
2020
Q3 | $3.32M | Buy |
|
|||||
|
2020
Q2 | $1.39M | Buy |
|